Search research articles
Contact Us
Filters
Showing results (31-40 of 42) with videos related to
Page
of 5
Sort By:
Blood
|
August 14, 2013
Egress of CD19(+)CD5(+) cells into peripheral blood following treatment with the Bruton tyrosine kinase inhibitor ibrutinib in mantle cell lymphoma patients
Betty Y Chang, Michelle Francesco, Martin F M De Rooij, et al.
ACS Pharmacology & Translational Science
|
December 18, 2025
An Assessment of Kinase Selectivity, Enzyme Inhibition Kinetics and in Vitro Activity for Several Bruton Tyrosine Kinase (BTK) Inhibitors
Ana Corrionero, Xiaohu Zhang, Patricia Alfonso, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 29, 2020
Randomized Phase II Study of First-Line Cladribine With Concurrent or Delayed Rituximab in Patients With Hairy Cell Leukemia
Dai Chihara, Evgeny Arons, Maryalice Stetler-Stevenson, et al.
Blood
|
February 21, 2019
Viral, immunologic, and clinical features of primary effusion lymphoma
Kathryn Lurain, Mark N Polizzotto, Karen Aleman, et al.
Blood
|
April 30, 2010
Genomewide DNA methylation analysis reveals novel targets for drug development in mantle cell lymphoma
Violetta V Leshchenko, Pei-Yu Kuo, Rita Shaknovich, et al.
Journal of Clinical Lipidology
|
February 12, 2015
Elevated interleukin-10: a new cause of dyslipidemia leading to severe HDL deficiency
Andreas G Moraitis, Lita A Freeman, Robert D Shamburek, et al.
Blood
|
April 2, 2011
Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States
Jeffrey I Cohen, Elaine S Jaffe, Janet K Dale, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 23, 2019
Randomized Phase III Trial of Ibrutinib and Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Non-Germinal Center B-Cell Diffuse Large B-Cell Lymphoma
Anas Younes, Laurie H Sehn, Peter Johnson, et al.
Cancer Research
|
August 24, 2012
Molecular subsets of mantle cell lymphoma defined by the IGHV mutational status and SOX11 expression have distinct biologic and clinical features
Alba Navarro, Guillem Clot, Cristina Royo, et al.
Academic Radiology
|
February 20, 2007
FDG-PET lymphoma demonstration project invitational workshop
Gary J Kelloff, Daniel M Sullivan, Wyndham Wilson, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 42) with videos related to
Sort By:
Page
of 5
Blood
|
August 14, 2013
Egress of CD19(+)CD5(+) cells into peripheral blood following treatment with the Bruton tyrosine kinase inhibitor ibrutinib in mantle cell lymphoma patients
Betty Y Chang, Michelle Francesco, Martin F M De Rooij, et al.
ACS Pharmacology & Translational Science
|
December 18, 2025
An Assessment of Kinase Selectivity, Enzyme Inhibition Kinetics and in Vitro Activity for Several Bruton Tyrosine Kinase (BTK) Inhibitors
Ana Corrionero, Xiaohu Zhang, Patricia Alfonso, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 29, 2020
Randomized Phase II Study of First-Line Cladribine With Concurrent or Delayed Rituximab in Patients With Hairy Cell Leukemia
Dai Chihara, Evgeny Arons, Maryalice Stetler-Stevenson, et al.
Blood
|
February 21, 2019
Viral, immunologic, and clinical features of primary effusion lymphoma
Kathryn Lurain, Mark N Polizzotto, Karen Aleman, et al.
Blood
|
April 30, 2010
Genomewide DNA methylation analysis reveals novel targets for drug development in mantle cell lymphoma
Violetta V Leshchenko, Pei-Yu Kuo, Rita Shaknovich, et al.
Journal of Clinical Lipidology
|
February 12, 2015
Elevated interleukin-10: a new cause of dyslipidemia leading to severe HDL deficiency
Andreas G Moraitis, Lita A Freeman, Robert D Shamburek, et al.
Blood
|
April 2, 2011
Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States
Jeffrey I Cohen, Elaine S Jaffe, Janet K Dale, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 23, 2019
Randomized Phase III Trial of Ibrutinib and Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Non-Germinal Center B-Cell Diffuse Large B-Cell Lymphoma
Anas Younes, Laurie H Sehn, Peter Johnson, et al.
Cancer Research
|
August 24, 2012
Molecular subsets of mantle cell lymphoma defined by the IGHV mutational status and SOX11 expression have distinct biologic and clinical features
Alba Navarro, Guillem Clot, Cristina Royo, et al.
Academic Radiology
|
February 20, 2007
FDG-PET lymphoma demonstration project invitational workshop
Gary J Kelloff, Daniel M Sullivan, Wyndham Wilson, et al.
Page
of 5